TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

La Thérapie Genio® de Nyxoah Bénéficie d'une Augmentation Significative du Remboursement Medicare en 2026 en Vertu de la Règle Finale du CMS

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Nyxoah Sa
La Thérapie Genio® de Nyxoah Bénéficie d'une Augmentation Significative du Remboursement Medicare en 2026 en Vertu de la Règle Finale du CMS

Nyxoah announced a substantial Medicare reimbursement increase for its Genio® sleep apnea treatment in 2026, with hospital outpatient services reimbursement rising 48% to $45,000 and ambulatory surgery center reimbursement increasing 58% to $42,373.

Insights
GOOG   neutral

Mentioned as providing warrant pledges as part of the financing arrangement


NYXH   positive

Received significant Medicare reimbursement increase, which should drive broader treatment adoption and expand commercial opportunities in US healthcare markets